U.S. markets close in 4 hours 19 minutes
  • S&P 500

    4,355.17
    +25.17 (+0.58%)
     
  • Dow 30

    34,143.71
    +73.29 (+0.22%)
     
  • Nasdaq

    13,347.97
    +123.99 (+0.94%)
     
  • Russell 2000

    1,784.79
    +2.97 (+0.17%)
     
  • Crude Oil

    90.14
    +0.51 (+0.57%)
     
  • Gold

    1,947.40
    +7.80 (+0.40%)
     
  • Silver

    23.89
    +0.20 (+0.84%)
     
  • EUR/USD

    1.0663
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    4.4380
    -0.0420 (-0.94%)
     
  • GBP/USD

    1.2268
    -0.0026 (-0.21%)
     
  • USD/JPY

    148.1900
    +0.6270 (+0.42%)
     
  • Bitcoin USD

    26,679.94
    +131.81 (+0.50%)
     
  • CMC Crypto 200

    568.84
    +0.79 (+0.14%)
     
  • FTSE 100

    7,686.55
    +7.93 (+0.10%)
     
  • Nikkei 225

    32,402.41
    -168.62 (-0.52%)
     

Altimmune to Present at Upcoming Investor and Scientific Conferences

GAITHERSBURG, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences:

  • Piper Sandler 33rd Annual Virtual Healthcare Conference
    November 29-December 2, 2021
    Webcast available now

  • 5th Annual NASH Summit 2021
    November 30, 2021
    9:00 am Eastern Time

  • 4th Annual Evercore ISI HealthCONx Conference
    December 2, 2021
    10:55 am Eastern Time

Presentation materials, including webcast links to the Piper Sandler and Evercore ISI presentations, will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com